Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods - Poll - MDSpire

Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods

  • By

  • Adrien Saucier

  • Bouchra Nasri

  • Britt McKinnon

  • Mabel Carabali

  • Laura Pierce

  • Katia Charland

  • Kate Zinszer

  • August 12, 2024

  • 0 min

Share

Original Source(s)

Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods

  • by Adrien Saucier, Bouchra Nasri, Britt McKinnon, Mabel Carabali, Laura Pierce, Katia Charland, Kate Zinszer

  • August 12, 2024

Related Content

Aggression and emotional distress in adolescents: a cross-sectional chain mediation model of internet addiction and somatization

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Perampanel use in pediatric autoimmune encephalitis-related seizures and epilepsy: a retrospective case series